Shanthanna Harsha, Busse Jason W, Thabane Lehana, Paul James, Couban Rachel, Choudhary Harman, Kaushal Alka, Suzumura Erica, Kim Isabel, Harsha Prathiba
Department of Anesthesia, McMaster University, St. Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, ON, L8N 4A6, Canada.
The Michael G. DeGroote Institute for Pain Research and Care, Hamilton, Canada.
Syst Rev. 2016 Feb 1;5:18. doi: 10.1186/s13643-016-0190-z.
Steroids are often combined with local anesthetic (LA) and injected to reduce pain associated with various chronic non-cancer pain (CNCP) complaints. The biological rationale behind injection of a steroid solution is unclear, and it is uncertain whether the addition of steroids offers any additional benefits over injection of LA alone. We propose to conduct a systematic review and meta-analysis to summarize the evidence for using steroids and LA vs. LA alone in the treatment of CNCP.
An experienced librarian will perform a comprehensive search of EMBASE, MEDLINE, and the Cochrane Central Registry of Controlled Trials (CENTRAL) databases with search terms for clinical indications, LA, and steroid agents. We will review bibliographies of all relevant published reviews in the last 5 years for additional studies. Eligible trials will be published in English and randomly allocate patients with CNCP to treatment with steroid and LA injection therapy or injection with LA alone. We will use the guidelines published by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to inform the outcomes that we collect and present. Teams of reviewers will independently and in duplicate assess trial eligibility, abstract data, and assess risk of bias among eligible trials. We will prioritize intention to treat analysis and, when possible, pool outcomes across trials using random effects models. We will report our findings as risk differences, weighted mean differences, or standardized mean differences for individual outcomes. Further, to ensure interpretability of our results, we will present risk differences and measures of relative effect for pain reduction based on anchor-based minimally important clinical differences. We will conduct a priori defined subgroup analyses and use the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to evaluate the certainty of the evidence on an outcome-by-outcome basis.
Our review will evaluate both the effectiveness and the adverse events associated with steroid plus LA vs. LA alone for CNCP, evaluate the quality of the evidence using the GRADE approach, and prioritize patient-important outcomes guided by IMMPACT recommendations. Our results will facilitate evidence-based management of patients with chronic non-cancer pain and identify key areas for future research.
PROSPERO CRD42015020614.
类固醇常与局部麻醉剂(LA)联合注射,以减轻与各种慢性非癌性疼痛(CNCP)相关的疼痛。注射类固醇溶液背后的生物学原理尚不清楚,且添加类固醇是否比单独注射LA有任何额外益处也不确定。我们建议进行一项系统评价和荟萃分析,以总结在治疗CNCP中使用类固醇和LA与单独使用LA的证据。
一位经验丰富的图书馆员将使用临床适应症、LA和类固醇药物的检索词,对EMBASE、MEDLINE和Cochrane对照试验中央注册库(CENTRAL)数据库进行全面检索。我们将查阅过去5年所有相关已发表综述的参考文献以寻找更多研究。符合条件的试验将以英文发表,并将CNCP患者随机分配接受类固醇和LA注射治疗或仅接受LA注射治疗。我们将使用临床试验方法、测量和疼痛评估倡议(IMMPACT)发布的指南来指导我们收集和呈现的结果。评审团队将独立且重复地评估试验的合格性、提取数据,并评估合格试验中的偏倚风险。我们将优先进行意向性分析,并在可能的情况下,使用随机效应模型汇总各试验的结果。我们将把我们的发现报告为个体结果的风险差异、加权平均差异或标准化平均差异。此外,为确保我们结果的可解释性,我们将基于基于锚定的最小重要临床差异呈现疼痛减轻的风险差异和相对效应量。我们将进行预先定义好的亚组分析,并使用推荐分级评估、制定和评价(GRADE)系统逐个结果地评估证据的确定性。
我们的综述将评估与单独使用LA相比,类固醇加LA治疗CNCP的有效性和不良事件,使用GRADE方法评估证据质量,并根据IMMPACT建议优先考虑对患者重要的结果。我们的结果将有助于对慢性非癌性疼痛患者进行循证管理,并确定未来研究的关键领域。
PROSPERO CRD42015020614